NCT00646100View on ClinicalTrials.gov

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

PHASE4CompletedINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

February 28, 2010

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE

transcatheter arterial chemoembolization

chemo-lipiodolization with EADM 50mg, Lobaplatin 50mg, and MMC 6mg,plus particleembolization.

Trial Locations (1)

510060

Cancer Canter Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT00646100 - Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis | Biotech Hunter | Biotech Hunter